Oct 27 (Reuters) - Albemarle said on Monday it
will sell a 51% stake in its refining catalyst solutions
business, Ketjen, to private equity firm KPS Capital Partners,
and divest its 50% interest in the Eurecat joint venture to
France's Axens SA, in deals worth about $660 million.